Business
US FDA approves use of Gilead’s remdesivir for hospitalised coronavirus patients – ABC News
The US Food and Drug Administration approves Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and…
The US Food and Drug Administration has approved Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and only drug approved for the disease in the United States.
- The FDA’s formal approval for remdesivir’s widespread use came hours before the final presidential debate
- However, the World Health Organization found the drug did not have a substantial effect on patients’ length of hospital stays or chances of survival
- Remdesivir will be sold…
Continue Reading
-
Noosa News20 hours agoBrisbane council budget 2025: Winners and losers
-
Noosa News23 hours agoSuspicious fire, Glenview – Sunshine Coast
-
Business15 hours ago3 of the best ASX stocks to buy now with $2,500
-
Noosa News14 hours agoRapist who tortured woman for weeks claims he deserves a lighter sentence for not letting her die